Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials (S01.007)
Timothy R. Vollmer, G. Comi, Peter Sørensen, Douglas L. Arnold, Massimo Filippi, О. А. Статінова, Tetyana Kobys, E. Becker, Diane L. Jeffery, Xavier Montalbán, Ludwig Kappos, Krzysztof Selmaj, Frauke Zipp, Eva Havrdová, Jeffrey A. Cohen (2012). Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials (S01.007). , 78(Meeting Abstracts 1), DOI: https://doi.org/10.1212/wnl.78.1_meetingabstracts.s01.007.
Article24 days agoBaseline characteristics of patients enrolled in CONCERTO - a study of 0.6 and 1.2 mg/day oral laquinimod for relapsing-remitting multiple sclerosis (P7.216)
Gıancarlo Comı, Timothy R. Vollmer, Xavier Montalbán, Tjalf Ziemssen, Alexey Boyко, Patrick Vermersch, Tamar Rachmilewitz, Noah J. Sasson, Tali Gorfine, Volker Knappertz, Maria A. Rocca, Massimo Filippi (2015). Baseline characteristics of patients enrolled in CONCERTO - a study of 0.6 and 1.2 mg/day oral laquinimod for relapsing-remitting multiple sclerosis (P7.216). , 84(14_supplement), DOI: https://doi.org/10.1212/wnl.84.14_supplement.p7.216.
Article24 days ago